Safety and efficacy of terfenadine/pseudoephedrine versus clemastine/phenylpropanolamine in the treatment of seasonal allergic rhinitis

Keyphrases

• Placebo 100%
• Seasonal Allergic Rhinitis 100%
• Terfenadine 100%
• Pseudoephedrine 100%
• Phenylpropanolamine 100%
• Clemastine 100%
• Insomnia 66%
• Adverse Events 66%
• Total Symptom Score 66%
• Dry Mouth 66%
• Physician Evaluation 66%
• Drowsiness 66%
• Immediate Release 66%
• Patient-physician 33%
• Randomized Placebo-controlled Trial 33%
• Days of Treatment 33%
• Parallel Trials 33%
• Individual Symptoms 33%
• Sustained Release 33%
• Patient Diaries 33%
• Effective Alternative 33%
• Controlled Release 33%
• Overall Effectiveness 33%
• Combination Tablet 33%
• Diary 33%
• Clemastine Fumarate 33%
• Overall Treatment Effect 33%
• Histamine-mediated 33%
• Nasal Congestion 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Symptom 100%
• Pollen Allergy 100%
• Terfenadine 100%
• Pseudoephedrine 100%
• Phenylpropanolamine 100%
• Clemastine 100%
• Placebo 50%
• Adverse Event 25%
• Xerostomia 25%
• Sustained Release 12%
• Histamine 12%
• Tablet 12%
• Nose Obstruction 12%
• Clemastine Fumarate 12%
• Controlled Release 12%